HYLORIS PHARMACEUTICALS SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.7 EUR | -1.27% |
|
-2.50% | -8.24% |
| 14/03 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
| 14/03 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
Chart calendar Hyloris Pharmaceuticals SA
115989179ca26cb51fd90b13.l7nhHeOKLMKyCNjx7KEywAFoM0H0J7_jW7J8hi8aazA.9OvMR6_hFfT_PLDEqfFgkFYFZjuyeM6BCcU5w2wvElPggY1Y0cl7mNpZ4A~50b634498355469df4fbc0ed3db90fb9
Upcoming events on Hyloris Pharmaceuticals SA
Past events on Hyloris Pharmaceuticals SA
| 14/03/2024 06:30 pm | Q4 2023 Earnings Call |
| 14/03/2024 11:30 am | Q4 2023 Earnings Release |
| 08/01/2024 | JPMorgan Healthcare Conference |
| 23/11/2023 | Degroof Petercam Belgian Day |
| 14/11/2023 | Jefferies London Healthcare Conference |
| 06/11/2023 | Bio-Europe Conference |
| 24/10/2023 | CPHI Conference |
| 09/10/2023 | De Belegger On Tour |
| 05/10/2023 | Investor Day |
| 27/09/2023 | Biotech On Tap Conference |
| 07/09/2023 07:30 pm | Q2 2023 Earnings Call |
| 07/09/2023 01:30 am | Q2 2023 Earnings Release |
| 13/06/2023 05:30 pm | Annual General Meeting |
| 05/06/2023 | BIO International Convention |
| 26/04/2023 | Kempen Lifesciences Conference |
| 20/03/2023 | DCAT Conference |
| 16/03/2023 06:30 pm | Q4 2022 Earnings Call |
| 15/03/2023 11:33 pm | Q4 2022 Earnings Release |
| 23/11/2022 08:30 pm | Business Update Call |
| 01/09/2022 10:30 am | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,09 | 0,18 0,95 -81.58% | 3,10 2,65 16.83% | 2,95 5,00 -40.98% | 4,41 7,35 -40.05% | 8,15 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | -4,49 -11,9 62.24% | -4,63 -13,0 64.35% | -10,4 -11,4 8.4% | -15,9 -12,2 -30.22% | -14,6 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | -5,08 -8,00 36.56% | -10,5 -13,0 18.92% | -10,6 -12,0 11.35% | -16,2 -12,2 -33.08% | -14,3 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | -7,15 -6,00 -19.08% | -11,3 -8,00 -41.03% | -10,8 -12,0 10.28% | 0,00 0,00 - | -13,0 |
|
Net income Million EUR | Released Forecast Spread | 0,00 | -7,15 -6,00 -19.08% | -11,6 -13,0 10.93% | -10,8 -12,0 10.25% | -15,8 -9,35 -68.58% | -14,1 |
|
EPS EUR | Released Forecast Spread | -1,49 | -0,33 -1,71 80.7% | -0,45 -0,53 15.09% | -0,40 -0,45 11.11% | 0,00 -0,60 - | -0,50 |
| Announcement Date | 16/06/20 | 09/03/21 | 16/03/22 | 15/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 S1 |
|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1,03 |
| Announcement Date | 01/09/22 |
More events
Past sector events for Hyloris Pharmaceuticals SA
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HYL Stock
- Calendar Hyloris Pharmaceuticals SA
